CLE
Clinical trials for CLE explained in plain language.
Never miss a new study
Get alerted when new CLE trials appear
Sign up with your email to follow new studies for CLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lupus skin flares: experimental drug VENT-03 enters Mid-Stage trial
Disease control Recruiting nowThis study tests whether an experimental drug called VENT-03 can reduce skin symptoms in people with cutaneous lupus (CLE), with or without systemic lupus (SLE). About 24 adults will receive either VENT-03 or a placebo for 4 weeks, then all will receive VENT-03 for 8 more weeks. …
Matched conditions: CLE
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug trial aims to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug, SAR448501/DR-0201, in 62 adults with lupus or rheumatoid arthritis. The goal is to find the safest and most effective dose by checking side effects and how the drug works in the body. Participants will be followed for about 13 months, and …
Matched conditions: CLE
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 04, 2026 16:24 UTC